Botanix Pharmaceutical (formerly: Bone Medical) is a pharmaceutical and biotechnology public listed company with the code as [ASX: BOT], which was founded in 2002 and is headquartered at Perth, Australia. It focuses on the treatment of joint and bone diseases. It aims to grab high potential market of skin diseases with its advancement in technology. It aims to add value by its clinical studies for acne, atopic and psoriasis dermatitis.
It has recently got approval for synthetic cannabidiol as a new product for skin treatment. These recent developments have put Botanix into the list of world’s most advanced cannabinoid companies. Its highly advanced permetrex